Anseong, South Korea

Mi-Ran Kim

This inventor holds 4 USPTO granted patents. Top assignee: Olipass Corporation. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mi-Ran Kim. Retrieved from https://idiyas.com/inventor/mi-ran-kim-gpkfz8e5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Location History:

  • Anseong-si, KR (2014)
  • Gyeonggi-do, KR (2014)

Company Filing History:


Years Active: 2014

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Mi-Ran Kim**

Introduction

Mi-Ran Kim, an accomplished inventor based in Anseong-si, South Korea, has made significant contributions to the field of biotechnology. With a total of four patents to her name, she stands out for her innovative work in peptide nucleic acid research, particularly in enhancing cell penetration and binding affinity for nucleic acids.

Latest Patents

Among Mi-Ran Kim's latest inventions are her novel peptide nucleic acid derivatives. These derivatives exhibit excellent cell penetration qualities and a strong affinity for nucleic acids. Her work in this area not only represents a breakthrough in the field but also promises potential applications in therapeutic and diagnostic technologies.

Career Highlights

Mi-Ran Kim is currently employed at Olipass Corporation, a company known for its cutting-edge research in the field of biotechnology. Her expertise and creativity have played a vital role in the development of innovative solutions that can impact the medical and scientific communities significantly.

Collaborations

Throughout her career, Mi-Ran has collaborated with notable colleagues, including Shin Chung and Heui-Yeon Kim. These partnerships have fostered a collaborative environment that has led to further advancements in their shared research interests.

Conclusion

In summary, Mi-Ran Kim is a notable inventor in the realm of peptide nucleic acids, with a commendable record of four patents. Her work at Olipass Corporation, along with her collaborations, showcases her dedication to innovation and the pursuit of scientific advancement. As she continues to push the boundaries of what is possible in biotechnology, her contributions will undoubtedly make a lasting impact.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…